36
Participants
Start Date
November 30, 2011
Primary Completion Date
May 31, 2013
Study Completion Date
October 31, 2013
anti-CD3 monoclonal antibody
Oral anti-CD3 MAb will be administered at a dosage level of 0.2 or 1.0 or 5.0 mg per day for 30 days. One 20mg tablet of Omeprazole (a proton pump inhibitor) will be taken concomitantly orally
Sodium Chloride placebo
Sodium chloride will be administered orally every day for 30 days. Up to 9 subjects will be treated at each dosage level. One 20mg tablet of Omeprazole (a proton pump inhibitor) will be taken concomitantly orally
Univ.Klinik für Innere Medizin IV, Vienna
Katedra i Klinika Chorób Zakaźnych i Hepatologii Wojewódzki Szpital Obserwacyjno - Zakaźny im. Tadeusza Browicza, Bydgoszcz
Lead Sponsor
Collaborators (1)
NasVax Ltd
INDUSTRY
Inspira Medical AB
INDUSTRY